Treatment of SMB-S15 Cells with Resveratrol Efficiently Removes the PrP(Sc) Accumulation In Vitro and Prion Infectivity In Vivo (Q38830007)

6 September 2017

title

Treatment of SMB-S15 Cells with Resveratrol Efficiently Removes the PrP(Sc) Accumulation In Vitro and Prion Infectivity In Vivo (English)

1 reference

6 September 2017

0 references

1 reference

8

Qi Shi

1 reference

6 September 2017

9

Xiao-Ping Dong

1 reference

6 September 2017

Jing Wang

1

1 reference

6 September 2017

Bao-Yun Zhang

2

1 reference

6 September 2017

Jin Zhang

3

1 reference

6 September 2017

Kang Xiao

4

1 reference

6 September 2017

Li-Na Chen

5

1 reference

6 September 2017

Hui Wang

6

1 reference

6 September 2017

Jing Sun

7

1 reference

6 September 2017

publication date

6 October 2015

1 reference

6 September 2017

published in

Molecular Neurobiology

1 reference

6 September 2017

volume

53

1 reference

6 September 2017

issue

8

1 reference

6 September 2017

page(s)

5367-5376

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

6 September 2017

1 reference

Prion diseases of humans and animals: their causes and molecular basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Progress and problems in the biology, diagnostics, and therapeutics of prion diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Resveratrol: a molecule whose time has come? And gone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Resveratrol: its biologic targets and functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Neuroprotective properties of resveratrol in different neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Neuroprotective effects of resveratrol in Alzheimer disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Sirtuins: common targets in aging and in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Sirtuins as possible targets in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Autophagy induced by the class III histone deacetylase Sirt1 prevents prion peptide neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Scrapie infection in experimental rodents and SMB-S15 cells decreased the brain endogenous levels and activities of Sirt1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Multiplication of the scrapie agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Mouse-adapted scrapie strains 139A and ME7 overcome species barrier to induce experimental scrapie in hamsters and changed their pathogenic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Specific inhibition of pathological prion protein accumulation by small interfering RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Novel proteinaceous infectious particles cause scrapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Recent advances in prion chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Resveratrol protects against global cerebral ischemic injury in gerbils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Increased oxidation, glycoxidation, and lipoxidation of brain proteins in prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9464-Z

Biological effects of resveratrol

21 January 2018

1 reference

12 December 2020

Dynamic analyses of PrP and PrP(Sc) in brain tissues of golden hamsters infected with scrapie strain 263K revealed various PrP forms.

1 reference

12 December 2020

Prion diseases - current theories and potential therapies: a brief review

1 reference

12 December 2020

Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP in mice inoculated with a mouse-adapted strain of the Creutzfeldt-Jakob disease agent

1 reference

12 December 2020

Oxidative stress and neurodegeneration in prion diseases

1 reference

12 December 2020

10.1007/S12035-015-9464-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1017089994

0 references

1 reference